| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPCELL.00185.2016 |
| P698 | PubMed publication ID | 28003225 |
| P50 | author | Adel Amirouche | Q79864007 |
| P2093 | author name string | Bernard J Jasmin | |
| John A Lunde | |||
| Nathalie Koulmann | |||
| Vanessa E Jahnke | |||
| Damien G Freyssenet | |||
| P2860 | cites work | MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease | Q24608809 |
| microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7 | Q24615529 | ||
| A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA | Q24630341 | ||
| The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
| Myostatin negatively regulates satellite cell activation and self-renewal | Q24675245 | ||
| Distinctive patterns of microRNA expression in primary muscular disorders | Q24675407 | ||
| Noncoding RNAs, Emerging Regulators of Skeletal Muscle Development and Diseases | Q26799919 | ||
| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo | Q28206290 | ||
| A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep | Q28244085 | ||
| Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133 | Q28286875 | ||
| The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 | Q28295943 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts | Q30416251 | ||
| miR-206 and -486 induce myoblast differentiation by downregulating Pax7 | Q30431651 | ||
| Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies. | Q39001797 | ||
| Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. | Q39443445 | ||
| Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma | Q39461214 | ||
| Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. | Q40767544 | ||
| Developmental myosins: expression patterns and functional significance | Q41600339 | ||
| miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells | Q41834079 | ||
| miRNAs as serum biomarkers for Duchenne muscular dystrophy | Q42126374 | ||
| Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis | Q42138750 | ||
| MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice | Q42722532 | ||
| Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation | Q42834742 | ||
| Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model | Q42914173 | ||
| Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics | Q45328178 | ||
| Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. | Q45940714 | ||
| Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle | Q46359311 | ||
| Combination of small RNAs for skeletal muscle regeneration. | Q50906519 | ||
| MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. | Q51948480 | ||
| Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. | Q54474181 | ||
| Fetal myosin heavy chains in regenerating muscle | Q57973483 | ||
| Muscle-specific microRNA miR-206 promotes muscle differentiation | Q30441356 | ||
| Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle. | Q33744468 | ||
| Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. | Q33894799 | ||
| Skeletal muscle homeostasis in duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy | Q33944130 | ||
| Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function | Q34005353 | ||
| The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
| Function and genetics of dystrophin and dystrophin-related proteins in muscle | Q34120764 | ||
| A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network | Q34154536 | ||
| MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3 | Q34218839 | ||
| Hmgb3 is regulated by microRNA-206 during muscle regeneration | Q34389648 | ||
| Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype | Q34505654 | ||
| Myogenic factors that regulate expression of muscle-specific microRNAs | Q34531532 | ||
| Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice | Q34627033 | ||
| The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle. | Q34748864 | ||
| TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. | Q34799828 | ||
| miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4 | Q34984485 | ||
| Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia | Q34986949 | ||
| Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy | Q35055089 | ||
| microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice | Q36005429 | ||
| Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. | Q36116761 | ||
| Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle | Q36321466 | ||
| Signaling pathways in skeletal muscle remodeling | Q36498310 | ||
| Cellular heterogeneity during vertebrate skeletal muscle development | Q36870830 | ||
| Activity-dependent signaling pathways controlling muscle diversity and plasticity | Q36910755 | ||
| Muscle diseases: the muscular dystrophies | Q37014693 | ||
| MicroRNA-206: the skeletal muscle-specific myomiR. | Q37125050 | ||
| Therapeutic advances in muscular dystrophy | Q37455625 | ||
| MicroRNA-206: a promising theranostic marker. | Q37511094 | ||
| MicroRNAs involved in skeletal muscle differentiation | Q38092278 | ||
| AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy | Q38124580 | ||
| Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. | Q38354619 | ||
| NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair | Q38444259 | ||
| Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle. | Q38594063 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | C209-C221 | |
| P577 | publication date | 2016-12-21 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations | |
| P478 | volume | 312 |
| Q45325968 | Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases |
| Q57288805 | Embryonic myosin is a regeneration marker to monitor utrophin based therapies for DMD |
| Q60938968 | Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach |
| Q91671976 | Molecular mechanisms and therapeutic interventions in sarcopenia |
| Q52714388 | Release of MicroRNAs into Body Fluids from Ten Organs of Mice Exposed to Cigarette Smoke. |
| Q57169212 | The oncomir face of microRNA-206: A permanent miR-206 transfection study |
| Q92621807 | miR-146a deficiency does not aggravate muscular dystrophy in mdx mice |
Search more.